ON
← Back to feed
Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says
United States🏛️ PoliticsCenter2 days ago

Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says

Discussions are ongoing between the Democratic Republic of the Congo (DRC) authorities and the World Health Organization (WHO) to accelerate the initiation of a Phase 3 clinical trial for Merck’s Ervebo vaccine, aimed at combating the Bundibugyo strain of Ebola in the northeastern DRC. WHO Director-General Tedros Adhanom Ghebreyesus noted that the current outbreak is the second-largest on record and growing rapidly. While the vaccine targets the Zaire strain, recent studies suggest it might offer cross-protection against Bundibugyo. The WHO recommends including Ervebo in the trial, which would involve randomly assigning participants to receive the vaccine or a placebo. The trial will not use the 'ring vaccination' method used in the successful Ebola Ça Suffit trial in Guinea, opting instead for individual randomization based on findings from subsequent trials. Over 4,500 cases have been confirmed in the DRC, with over 2,060 deaths.

An ongoing Ebola outbreak in the Democratic Republic of Congo appears poised to become the deadliest in history, according to data released by health officials and the African Centre for Disease Control and Prevention (Africa CDC). As of late August, the outbreak has claimed over 2,300 lives, surpassing the toll of the previous worst Ebola crisis in the country, which occurred between 2018 and 2020. With nearly 5,300 confirmed cases, the outbreak is growing at an alarming pace, with projections suggesting it could reach sizes three times larger than the current numbers. The outbreak, attributed to the Bundibugyo strain of the Ebola virus, was officially declared on May 15. However, preliminary investigations suggest that the virus may have begun circulating in the mining town of Mongbwalu as early as February, several months prior to the formal announcement. This delayed detection has complicated containment efforts, allowing the virus to spread further than initially anticipated. Health officials warn that the outbreak is progressing much faster than previous ones. According to Africa CDC data, the current outbreak is moving 18 times faster in terms of confirmed cases compared to the 2018–2020 outbreak, and 13 times faster in terms of deaths. By the 13th week following the declaration, the number of cases and fatalities already exceeded historical records. In comparison, the 2014–2016 West Africa Ebola outbreak, which resulted in over 11,000 deaths, had reached 28,000 cases by the end of its duration. Contact tracing efforts remain insufficient, with only 16 percent of expected contacts traced so far. Experts estimate that the actual number of cases is significantly higher due to limited awareness among the population and challenges in reaching remote areas. Many individuals are reluctant to seek medical help, either due to mistrust of healthcare providers or a belief that the outbreak is not real. Traditional healing practices are often preferred over modern medical interventions, further complicating efforts to contain the spread. The outbreak has expanded beyond its initial epicenter, with cases now reported in five provinces, including the previously unaffected Bas-Uele province. This expansion indicates that the virus is gaining momentum in regions that lacked prior exposure. Despite this, some areas show signs of improvement. For example, South Kivu province has gone 79 days without reporting any new cases, suggesting localized containment successes. Efforts to combat the outbreak include the deployment of Merck’s Ebola vaccine, Ervebo, which is designed to protect against a different strain of the virus. While not specifically tailored for the Bundibugyo strain, the vaccine is being used in a clinical trial alongside distribution to frontline workers. Additionally, research initiatives are exploring potential cross-protection from existing vaccines targeting other strains of Ebola and related viruses like Marburg. Community engagement is proving crucial in managing the outbreak. Local motorbike riders, who frequently transport patients and deceased individuals, are being recruited as part of the response strategy. Their involvement helps in identifying new cases and ensuring timely testing and treatment. Efforts are also focused on improving burial practices to prevent further transmission through contaminated environments. Healthcare infrastructure has been bolstered with the addition of 400 new beds in treatment facilities and the deployment of additional epidemiologists and community health workers. Safe burial practices are being promoted to reduce the risk of infection during funeral rites, which have historically contributed to the spread of the virus. The World Health Organization (WHO) has emphasized the importance of community engagement in controlling the outbreak. Dr Thierno Baldé, WHO Incident Manager for the Bundibugyo virus disease in the DRC, noted that despite the challenges, teams are working tirelessly to manage the situation. He described the response as multifaceted, involving both technical and community-based strategies to address the complex dynamics of the outbreak. With the situation evolving rapidly, health officials continue to monitor developments closely. The International Health Regulations Emergency Committee is set to meet again to assess the current risk levels and provide guidance to affected countries. As the outbreak continues to unfold, the focus remains on expanding containment measures and enhancing community participation in the response effort.

Go to the primary sources (7)

The official sources this coverage is built on. Read them directly to bypass framing.

6 reports

UN News logoUN NewsState / PublicCenterFactual 95Objective 888 days ago
Former rebel fighters join campaign against Ebola in the DR Congo

In the Democratic Republic of the Congo (DRC), former rebel fighters who have been demobilized are now participating in public awareness campaigns aimed at curbing the spread of Ebola in the eastern region. Twenty-seven ex-combatants are working as community mobilizers in the Tchomia locality of Ituri Province, promoting preventive behaviors such as handwashing and encouraging prompt reporting of suspected cases. The current Ebola outbreak, caused by the Bundibugyo strain, has already resulted in over 2,000 deaths and is expanding rapidly due to factors like conflict, poor infrastructure, and limited healthcare access. The United Nations peacekeeping mission, MONUSCO, has supported this initiative, viewing it as both a public health measure and a strategy to enhance community stability.

Bias read (Center): The article presents a balanced view of the situation, focusing on the collaboration between former rebels and health authorities without taking a clear ideological stance. It highlights the role of MONUSCO and local NGOs while providing factual information about the Ebola outbreak and its impact. S

Why factuality (95): The article accurately reports that demobilized former rebel fighters are participating in public information campaigns in the DRC to combat Ebola. It references the Bundibugyo strain, which aligns with the primary source document mentioning outbreaks in various regions including the DRC. The mentio

Why objectivity (88): The article presents the involvement of former rebels in combating Ebola neutrally, focusing on their role as community mobilizers. However, it uses emotionally charged language such as 'deadly outbreak' and 'threatening to spread,' which could be seen as slightly biased towards emphasizing the seve

UN News logoUN NewsState / PublicCenterFactual 85Objective 805 days ago
Ebola: Motorbike riders carrying the sick may hold key to response boost

An Ebola outbreak in the Democratic Republic of the Congo (DRC) has reached alarming levels, with 2,325 deaths reported, surpassing previous records. Dr. Thierno Baldé, WHO Incident Manager, highlighted the challenges faced by responders, including attacks on ambulances and the difficulty of gaining community trust. He emphasized the critical role of motorbike riders in transporting patients and deceased, noting they are among the most affected groups due to their exposure. To improve response efforts, the WHO aims to involve these riders as surveillance officers, enabling faster identification of suspected cases. Additional resources, including 100 epidemiologists, 500 community health workers, and 400 new beds, are being deployed to enhance treatment capacity and safer burial practices.

Bias read (Center): The article presents a factual update on the Ebola outbreak without overtly favoring any political group or ideology. While it discusses the involvement of local communities and government data, there is no clear ideological slant in the framing or emphasis. The focus remains on public health and on

Why factuality (85): The article provides specific information about the outbreak including death tolls (2,325), fatality rates (46%), and expansion to a sixth province (Bas-Uele). These details align with typical reporting on outbreaks and are consistent with the general timeframe mentioned in the primary source docume

Why objectivity (80): The article presents both challenges ('difficult situations') and efforts ('people are working here days and nights'). It includes direct quotes from a WHO official without obvious bias, though it emphasizes the difficulties faced by responders.

STAT News logoSTAT NewsIndependentCenterFactual 85Objective 7511 days ago
Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says

Discussions are ongoing between the Democratic Republic of the Congo (DRC) authorities and the World Health Organization (WHO) to accelerate the initiation of a Phase 3 clinical trial for Merck’s Ervebo vaccine, aimed at combating the Bundibugyo strain of Ebola in the northeastern DRC. WHO Director-General Tedros Adhanom Ghebreyesus noted that the current outbreak is the second-largest on record and growing rapidly. While the vaccine targets the Zaire strain, recent studies suggest it might offer cross-protection against Bundibugyo. The WHO recommends including Ervebo in the trial, which would involve randomly assigning participants to receive the vaccine or a placebo. The trial will not use the 'ring vaccination' method used in the successful Ebola Ça Suffit trial in Guinea, opting instead for individual randomization based on findings from subsequent trials. Over 4,500 cases have been confirmed in the DRC, with over 2,060 deaths.

Bias read (Center): The article presents information about a medical and public health initiative without overtly favoring any political ideology. It reports on scientific developments and international collaboration without taking a clear stance on political issues, maintaining a balanced tone.

Why factuality (85): The article accurately describes the ongoing discussions around a Phase 3 clinical trial for an Ebola vaccine in the DRC and quotes WHO Director-General Tedros Adhanom Ghebreyesus regarding the potential scale of the outbreak. However, it does not mention the ICG on vaccine provision, which is centr

Why objectivity (75): The article presents information objectively, quoting officials and describing the situation without overt bias. However, it uses phrases like 'on track to become the largest Ebola outbreak on record' and 'moving faster than any previous Ebola outbreak,' which may imply urgency or alarmism, slightly

The Washington Times logoThe Washington TimesParty-alignedCenterFactual 75Objective 602 days ago
Here's data that shows Congo's Ebola outbreak is on track to surpass history's largest

An Ebola outbreak in the Democratic Republic of Congo is expanding rapidly, potentially surpassing the deadliest outbreak in history. According to data from the Africa CDC and the World Health Organization, the current outbreak has recorded ten times more cases and seven times more deaths than the 2014-2016 West African outbreak within 13 weeks. As of the latest report, 2,516 deaths have been recorded out of 5,290 confirmed cases, with only 30%-40% of cases detected. Contact tracing remains incomplete, with only 16% of expected contacts identified. Experts warn that the outbreak may have begun as early as February, and the Bundibugyo virus, which lacks approved vaccines or treatments, is responsible. The outbreak has spread to 56 health zones across six provinces, including previously unaffected areas.

Bias read (Center): The article presents factual data and expert assessments without overtly favoring any political ideology. It reports on the severity and progression of the Ebola outbreak using objective metrics from authoritative sources like the Africa CDC and WHO. While the situation is politically significant as

Why factuality (75): The article makes several specific claims about case numbers and comparisons to past outbreaks, but does not cite primary sources like the WHO or DRC health authorities. Some figures appear exaggerated compared to the primary document which mentions the outbreak starting in May 2026 but provides no

Why objectivity (60): The article uses emotionally charged language such as 'unprecedented speed', 'deadliest on record', and 'intensely mobile population' which frames the outbreak as particularly dire. It also presents the Africa CDC representative's statements without counterbalancing perspectives.

Semafor logoSemaforIndependentCenterFactual 40Objective 703 days ago
Exclusive / US warns ‘long’ road ahead in Ebola response

The article reports that U.S. officials have expressed concerns about the ongoing challenges in the global response to the Ebola outbreak, emphasizing that the situation remains complex and requires sustained efforts. While the piece highlights the difficulties faced by health authorities, it does not provide specific details about the current state of the outbreak, the number of cases, or the exact measures being taken to contain it. The focus appears to be on the broader implications of the crisis rather than presenting a comprehensive update on the epidemic itself. No direct quotes from officials or detailed data are included, which limits the depth of the report.

Bias read (Center): The article presents a general warning from U.S. officials about the prolonged nature of the Ebola response without taking a clear ideological stance. It avoids overtly criticizing or praising any particular group or policy, maintaining a balanced tone. There is no strong emphasis on either side of政

Why factuality (40): The article references the outbreak but provides very limited specific information. It mentions the US warning about a 'long road ahead' but doesn't quantify the situation or provide concrete details about case numbers or response efforts. The primary source document would need to be consulted for v

Why objectivity (70): The article presents the situation as challenging but avoids overtly negative or alarmist language. It quotes a WHO official without apparent bias, though it focuses primarily on the challenges rather than any progress being made.

STAT News logoSTAT NewsIndependentCenterFactual 30Objective 852 days ago
Scientists deploy Merck’s Ebola vaccine in DRC

Scientists are deploying Merck’s Ebola vaccine, Ervebo, in the Democratic Republic of the Congo (DRC) amid a rapidly expanding Ebola outbreak. This marks an unusual step in the fight against the disease, as efforts focus on containing the spread through vaccination. Previous research has explored whether existing Ebola vaccines, including Ervebo, can generate immune responses against different strains such as Bundibugyo. The deployment comes as the situation in the DRC becomes increasingly urgent, with public health officials seeking effective interventions.

Bias read (Center): The article reports on the scientific deployment of a vaccine during an outbreak, focusing on medical and public health actions rather than political decisions or ideological framing. There is no clear slant in the language or emphasis, and the content remains focused on factual developments in theD

Why factuality (30): The article is largely unrelated to the Ebola outbreak in the DRC, focusing instead on prostate cancer treatments and Meta's AI glasses. There is minimal connection to the actual event described in the primary source document. No relevant facts about the Ebola outbreak are presented.

Why objectivity (85): The article maintains a neutral tone about the unrelated content it covers. However, it completely ignores the topic of the Ebola outbreak in the DRC, making it irrelevant to the event in question.

How each side covered it

The same event, grouped by the political lean of the outlets covering it.

How each side covered it

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Covered around the world

The same event as reported in other countries.

Covered around the world

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Claims check

Key factual claims, and how many sources assert vs dispute each.

Claims check

Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.

Become a Supporter

Keep the news honest.

ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €4/month.

Become a Supporter

Related stories